Ceftaroline: a cephalosporin with expanded Gram-positive activity. - Wikidata - wikimedia - TriplyDB

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

http://www.wikidata.org/entity/Q34016030

about

Comparative pharmacokinetics of ceftaroline in rats, rabbits, and monkeys following a single intravenous or intramuscular injection.Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia Advances in MRSA drug discovery: where are we and where do we need to be?Ceftobiprole: a new cephalosporin for the treatment of skin and skin structure infections.Antibiotic management of febrile neutropenia: current developments and future directions.Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.Acute bacterial skin and skin structure infections: current perspective.In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria Novel antibiotics for the treatment of Staphylococcus aureus.Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity.Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience.

P2860

Q33613654-851FC5C3-69A8-45A2-B3C6-8FA63AE4F2E3 Q35117981-A7FF5720-F785-4107-8ABB-0629786650BE Q35556737-91185FB5-F562-4212-87F0-AEFB8C0F27FB Q35752997-0C704EAC-C8B2-49E9-AB43-FA4FC4ADA51F Q37112508-79C499DC-FF3C-4338-A025-3279917EA441 Q37593094-0330E421-E0FC-4297-A82F-947A38A91B94 Q37708866-7EE1E023-2028-42CD-BF4D-BC3EA924F618 Q37785546-D142F39E-1A77-4088-8C3F-5D8D85BE11F4 Q37947221-E4A626A9-1029-43BA-9D20-80E8C3168D01 Q39268884-613A23C8-A95A-4B8B-AF61-55C3568CDD78 Q39895467-1C1C555B-0BA9-44FA-BF7A-95048BA5F909 Q39933945-6F3BBD55-CBAE-452F-8DFB-5B11F27C5819 Q42111061-06804B67-9ED5-474E-A505-E5CC61472CC8 Q42790618-EBF6E928-946D-452B-B798-440AAD7C9976 Q54292686-BCA05229-B9D3-4C13-9C87-EAB41E6F203F

P2860

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

http://www.wikidata.org/entity/Q34016030

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@ast

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@en

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@nl

type

label

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@ast

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@en

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@nl

prefLabel

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@ast

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@en

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@nl

P1433

Q34016030-40BABC2C-D33C-45D3-860F-1D1721A1DAA2

P1476

Q34016030-C4A9D053-8789-4831-8DCF-43B4F3751366

P2093

Q34016030-2CECEC78-0705-458B-9151-C9E8DCA9AFFC

Q34016030-DFFFC330-2D40-472D-9DB7-FA19B322D659

P2860

Q34016030-10B12411-0040-40BF-A5B9-62CE518BF888

Q34016030-1B16FF2A-D2F8-4B10-9C4A-8E48D131B1AE

Q34016030-22132264-43F5-41BC-BF7D-A40E905AEB27

Q34016030-3B3D125D-D925-41B4-897A-2C8A5E954CEA

Q34016030-4004AD60-7D9E-497E-A6FF-C3A7E1F39584

Q34016030-4151BF0F-9750-4C84-A723-584A4F00C5B9

Q34016030-42B69102-BEFB-459A-A619-C53C69B59871

Q34016030-44D3B3DF-120D-4570-A630-28B6273CB88A

Q34016030-4628AD85-2C54-4D7D-AE39-BF6B9443D8AE

Q34016030-6ACCD706-5EBB-4014-99BB-5DD823EB0A75

P304

Q34016030-8FCEA636-8387-46F5-AF28-686BC62E661C

P31

Q34016030-0584B0EB-3FB2-419F-AC11-EC9711AA0B8B

P356

Q34016030-3FAD648A-755C-4CA6-BDE1-732108E58A2C

P433

Q34016030-D17D7532-F78C-40BF-86E2-DB21DA3220C2

P478

Q34016030-C4A5882E-416D-4547-A92E-F2E5F880A6B3

P577

Q34016030-B9CA7E2A-6343-43AD-B763-F47FC782BFCC

P698

Q34016030-1914F908-4A0A-444F-94EB-79CE75C5A2B4

P921

Q34016030-73FE1EC5-FD90-4FB5-B6A1-E689ECA5B981

P356

17460913.4.1.25

P1433

Future Microbiology

P1476

Ceftaroline: a cephalosporin with expanded Gram-positive activity.

@en

P2093

G Ralph Corey

http://www.w3.org/2001/XMLSchema#string

Zeina A Kanafani

http://www.w3.org/2001/XMLSchema#string

P2860

Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.

TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties.

Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.

The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.

In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.

In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.

P304

25-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/17460913.4.1.25

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19207097

http://www.w3.org/2001/XMLSchema#string

P921

Gram-positive bacteria